Orion Infusion Limited announcements
236 Dhaka Stock Exchange announcements for Orion Infusion Limited (ORIONINFU) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (28).
- Refer to their earlier news disseminated by DSE on 14.11.2022 regarding Dividend Declaration, the company has further in
Refer to their earlier news disseminated by DSE on 14.11.2022 regarding Dividend Declaration, the company has further informed that the decision regarding raising of paid up capital through issuance of 10\% stock dividend for the year ended June 30, 2022 has been rejected by Bangladesh Securities and Exchange Commission. (cont.)
- BSEC rejected issuance of 10% Stock Dividend
(Continuation news of ORIONINFU): The company has also informed BSEC has advised that for the interest of the investors the company may declare additional 10% cash dividend instead of 10% bonus shares, if permitted by related laws, rules & regulations. (end)
The first part of this announcement is missing from the archive. - Decision to convert 10% stock dividend to 10% cash dividend
Referring to letter from Bangladesh Securities and Exchange Commission Ref: BSEC/CI/CPLC(Public)-1051/2022-1106, dated December 22, 2022, the company has further informed that the Board of Directors has taken decision to convert 10% stock dividend to 10% cash dividend i.e. total 20% cash dividend for the financial year ended June 30, 2022, subject to the approval of shareholders in the AGM to be held on December 28, 2022. The record date shall remain unchanged as December 04, 2022.
- Query Response
In response to a DSE query dated December 08, 2022, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.
- Resumption after record date
Trading of the shares of the Company will resume on 05.12.2022 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 04.12.2022.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 30.11.2022 to 01.12.2022. Trading of the shares will remain suspended on record date i.e., 04.12.2022.
- The auditor of the the Orion Infusion Limited has given the \"Emphasis of Matters\" paragraph in the Auditor\'s Report f
The auditor of the the Orion Infusion Limited has given the \"Emphasis of Matters\" paragraph in the Auditor\'s Report for the year ended 30 June 2022. Emphasis of Matter: Without modifying our opinion, we draw attention to note-7.01 to the financial statements, where the management has explained the status of investment in non-quoted shares classified as sponsor shares of ICB Islamic Bank Limited. An appeal is still pending with the High Court Division of Hon\'ble Supreme Court regarding (cont.1)
- (Continuation news of ORIONINFU): the investment whereas the company have the verdict in favour of them. Note 07.01 Inve
(Continuation news of ORIONINFU): the investment whereas the company have the verdict in favour of them. Note 07.01 Investment in Non-Quoted Shares: The investment in ICB Islamic Bank Ltd. as on 30 June 2022 was Tk. 16,825,396 and as on 30 June 2021 was Tk. 16,825,396. Orion Infusion has investment in 4,000 number of unquoted shares categorized as sponsor shares of ICB Islamic Bank Ltd., which was approved by (cont.2)
The first part of this announcement is missing from the archive. - Emphasis of Matters
(Continuation news of ORIONINFU):Bangladesh Securities and Exchange Commission as per regulation 42 of the listing regulations of the stock exchanges and relevant law applicable for Bank dated 14.07.2004. An appeal is still pending with the High Court Division of Hon'ble Supreme Court regarding the claim against the shares whereas the company have the verdict in favour of them. (end)
The first part of this announcement is missing from the archive. - Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.63 for July-September 2022 as against Tk. 0.72 for July-September 2021. NOCFPS was Tk. 0.06 for July-September 2022 as against Tk. 0.07 for July-September 2021. NAV per share was Tk. 14.80 as on September 30, 2022 and Tk. 14.22 as on June 30, 2022. EPS has decreased compared to the same period of last year due to decrease in revenue.
- The Board of Directors has recommended 10\% Cash and 10\% Stock Dividend for the year ended June 30, 2022. The Stock Div
The Board of Directors has recommended 10\% Cash and 10\% Stock Dividend for the year ended June 30, 2022. The Stock Dividend is subject to the approval of BSEC. Date of AGM: 28.12.2022, Time: 4:00 PM, Venue: Digital Platform. Record Date: 04.12.2022 for entitlement of cash dividend and another record date for entitlement of Stock Dividend will be notified later after getting approval from BSEC. The Company has also reported EPS of Tk. 2.10, NAV per share of Tk. 14.22 and NOCFPS of Tk. 2.23 (cont.1)
- (Continuation news of ORIONINFU):for the year ended June 30, 2022 as against Tk. 1.37, Tk. 13.10 and Tk. 1.40 respective
(Continuation news of ORIONINFU):for the year ended June 30, 2022 as against Tk. 1.37, Tk. 13.10 and Tk. 1.40 respectively for the same period of the previous year. Reasons for deviation in EPS and NOCFPS: EPS increased due to increase in sales. NOCFPS increased due to increase in cash collection from customers & others and decrease in payment to suppliers & others. The Company has also informed that a) Stock dividend has been recommended in order to meet regulatory requirements to raise capital;(cont.2)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (14.11.2022) following its corporate declaration. However, as per the BSEC Order No. BSEC/CMRRCD/2001-07/39 dated July 28, 2022, the floor price shall be applicable accordingly.
- Dividend Declaration
(Continuation news of ORIONINFU):b) Stock dividend has been recommended out of the current year's profit of the Company subject to the approval from Bangladesh Securities and Exchange Commission; c) Stock dividend has not been declared from capital reserve or revaluation reserve or any unrealized gain or out of profit earned prior to incorporation of the Company or through reducing paid-up capital or through doing anything so that the post-dividend retained earnings become negative or a debit balance.(end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2022 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2022.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2022 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.
- Query Response
In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike of shares.
- Query Response
In response to a DSE query dated September 19, 2022, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.
- Query Response (Repeat)
(Repeat): In response to a DSE query dated August 25, 2022, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.
- Query Response
In response to a DSE query dated August 25, 2022, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.
- Query Response
In response to a DSE query dated August 03, 2022, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.45 for January-March 2022 as against Tk. 0.33 for January-March 2021; EPS was Tk. 1.43 for July 2021-March 2022 as against Tk. Tk. 1.12 for July 2020-March 2021. NOCFPS was Tk. 0.26 for July 2021-March 2022 as against Tk. 0.53 for July 2020-March 2021. NAV per share was Tk. 13.55 as on March 31, 2022 and Tk. 13.10 as on June 30, 2021. Reason for deviation of EPS: EPS increased due to increase of sales during this financial period than that of the previous corresponding period
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 26, 2022 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2022.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.26 for October-December 2021 as against Tk. 0.32 for October-December 2020; EPS was Tk. 0.98 for July-December 2021 as against Tk. 0.79 for July-December 2020. NOCFPS was Tk. 0.23 for July-December 2021 as against Tk. 3.45 for July-December 2020. NAV per share was Tk. 13.09 as on December 31, 2021 and Tk. 13.10 as on June 30, 2021.
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2021 to the respective shareholders.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2022 at 5:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2021.
- Credit Rating Agency of Bangladesh Limited (CRAB) has announced the entity rating (surveillance) of the Company as \"A3\
Credit Rating Agency of Bangladesh Limited (CRAB) has announced the entity rating (surveillance) of the Company as \"A3\" along with a stable outlook based on audited financial statements as of June 30, 2021, bank liability position as of November 30, 2021 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.